Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RHEB | Q15382 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14359930 | 0.86 | — | — | |
| SCHEMBL14439036 | 0.84 | RHEB (0.32) | RHEB | |
| SCHEMBL3802014 | 0.84 | — | — | |
| SCHEMBL14042033 | 0.83 | RHEB (0.33) | RHEBALDH1A1CYP3A4 | |
| SCHEMBL13096070 | 0.83 | GBA1 (0.32) | RHEB | |
| SCHEMBL13095942 | 0.83 | GBA1 (0.32) | RHEB | |
| SCHEMBL13095949 | 0.81 | GBA1 (0.31) | RHEB | |
| SCHEMBL13095948 | 0.81 | GBA1 (0.31) | RHEB | |
| SCHEMBL13096071 | 0.81 | GBA1 (0.31) | RHEB | |
| SCHEMBL14265320 | 0.81 | GBA1 (0.31) | RHEB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170306233-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
| US-20170292075-A1 | POLYMERIZABLE COMPOSITION AND FILM USING SAME | DIC CORPORATION (JP) | 2017-10-12 | — | — | US | disclosed |
| US-20170260150-A1 | POLYMERIZABLE COMPOUND, COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, LIQUID CRYSTAL DISPLAY ELEMENT, AND ORGANIC EL DEVICE | DIC CORPORATION (JP) | 2017-09-14 | — | — | US | disclosed |
| US-20170205669-A1 | IMAGE DISPLAY DEVICE AND ORIENTED MATERIAL USED IN SAME | DIC CORPORATION (JP) | 2017-07-20 | — | — | US | disclosed |
| US-20170190972-A1 | LIQUID CRYSTAL DISPLAY DEVICE | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2017-07-06 | — | — | US | disclosed |
| US-9688787-B2 | Polymerizable compound having lateral substituent in terminal ring structure | DIC CORPORATION (JP) | 2017-06-27 | — | — | US | disclosed |
| US-9676959-B2 | Polymerizable composition solution and optically anisotropic body including the same | DIC CORPORATION (JP) | 2017-06-13 | — | — | US | disclosed |
| WO-2017090418-A1 | POLYMERIZABLE COMPOSITION AND OPTICALLY ANISOTROPIC BODY USING SAME | DIC株式会社 | 2017-06-01 | — | — | WO | disclosed |
| US-9645491-B2 | Sulfonium salt, chemically amplified resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-05-09 | — | — | US | disclosed |
| EP-2847200-B1 | IMIDAZOTHIADIAZOLE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION | BRISTOL MYERS SQUIBB CO (US) | 2017-03-29 | — | — | EP | disclosed |
| US-8168649-B2 | Niacin receptor agonists, compositions containing such compounds and methods of treatment | Merk Sharp & Dohme Corp. (US) | 2012-05-01 | — | — | US | disclosed |
| US-8105760-B2 | Patterning process and pattern surface coating composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-01-31 | — | — | US | disclosed |
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CHISSO CORPORATION (JP) | 2011-04-14 | — | — | US | disclosed |
| US-20100159392-A1 | PATTERNING PROCESS AND RESIST COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100144778-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | MERCK SHARP & DOHME LLC | 2010-06-10 | — | — | US | disclosed |
| US-20100144778-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | MERCK SHARP & DOHME LLC | 2010-06-10 | — | — | US | disclosed |
| US-20090053657-A1 | PATTERNING PROCESS AND PATTERN SURFACE COATING COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-7360883-B2 | Active ray curable ink, image forming method and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-04-22 | — | — | US | disclosed |
| WO-2007002557-A1 | NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK & CO., INC. (US) | 2007-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170260150-A1 | POLYMERIZABLE COMPOUND, COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, LIQUID CRYSTAL DISPLAY ELEMENT, AND ORGANIC EL DEVICE | RPL19, RPL24, RPL29 | RHEB 1738/4885TSHR 4519/4885ALDH1A1 2675/4885 |
| US-20110086185-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND AND ITS POLYMER | CCNT1, POF1B, CCND3 | RHEB 3718/4885TSHR 3371/4885ALDH1A1 926/4885 |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | CBR3, CBR1, CNR1 | RHEB 2431/4885TSHR 2029/4885ALDH1A1 3110/4885 |
| US-20170306233-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | SMC4, PHOSPHO1, SMCHD1 | RHEB 1250/4885TSHR 4855/4885ALDH1A1 2761/4885 |
| US-20100144778-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | HCAR1, HCAR2, GPR119 | RHEB 3726/4885TSHR 735/4885ALDH1A1 1145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.